α-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells

Author： Yu Weiping Shun Ming-chieh Anderson Kristen Chen Hansong Sanders Bob Kline Kimberly

ISSN： 1360-8185

Source： Apoptosis, Vol.11, Iss.10, 2006-10, pp. : 1813-1823

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells

By Schneiderman D. Kim J.-M. Senterman M. Tsang B.K.

Apoptosis, Vol. 4, Iss. 4, 1999-08 ,pp. : 271-282

Springer Publishing Company

Access to resources Recommend Favorite

Oestradiol inhibits spontaneous and cisplatin-induced apoptosis in epithelial ovarian cancer cells: relationship to DNA repair capacity

By Murdoch W. J. Van Kirk E. A.

Apoptosis, Vol. 2, Iss. 5, 1997-01 ,pp. : 478-484

Springer Publishing Company

Access to resources Recommend Favorite

Induction of apoptosis by gemcitabine in BG-1 human ovarian cancer cells compared with induction by staurosporine, paclitaxel and cisplatin

By Cartee L.

Apoptosis, Vol. 3, Iss. 6, 1998-12 ,pp. : 439-449

Springer Publishing Company

Access to resources Recommend Favorite

Cross-Resistance, Cisplatin Accumulation, and Platinum-DNA Adduct Formation and Removal in Cisplatin-Sensitive and -Resistant Human Hepatoma Cell Lines

By Johnson S.W. Shen D.-W. Pastan I. Gottesman M.M. Hamilton T.C.

Experimental Cell Research, Vol. 226, Iss. 1, 1996-07 ,pp. : 133-139

Elsevier

Access to resources Recommend Favorite

Electrochemical Monitoring of Anticancer Compounds on the Human Ovarian Carcinoma Cell Line A2780 and Its Adriamycin- and Cisplatin-Resistant Variants

By Woolley D.E. Tetlow L.C. Adlam D.J. Gearey D. Eden R.D. Ward T.H. Allen T.D.

Experimental Cell Research, Vol. 273, Iss. 1, 2002-02 ,pp. : 65-72

Elsevier

Access to resources Recommend Favorite